Instem has acquired a small software business, Samarind, which is active in the market for Regulatory Information Management – helping pharmaceutical companies deliver required details about products actually being sold (ie post-approval) as well as those in the later stages of development. This is a major move for Instem, and we believe it fits well with, and extends, the successful expansions already under way.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Samarind acquisition
- Published:
02 Jun 2016 -
Author:
Gareth Evans -
Pages:
6
Instem has acquired a small software business, Samarind, which is active in the market for Regulatory Information Management – helping pharmaceutical companies deliver required details about products actually being sold (ie post-approval) as well as those in the later stages of development. This is a major move for Instem, and we believe it fits well with, and extends, the successful expansions already under way.